Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF)

📢 Exciting News!     Our CEO, Donato Bonifazi, has been elected to the Coordinating Group of European Network of Paediatric Research at EMA (Enpr-EMA) for 2025-2027, representing TEDDY Network!     TEDDY continues to shape paediatric research in Europe through active participation in multiple Enpr-EMA working groups and will now contribute even more directly to advancing children's medicines development through this strategic position.    First Coordinating Group meeting: March 2025 https://lnkd.in/d_YpECd7   #PaediatricResearch #Innovation #TEDDY #EnprEMA #ChildrenFirst #ClinicalResearch #CVBF 

📢 Wrapping up an inspiring team building in Bari! As we continue to grow, we're thrilled to announce our commitment to invest €200K in paediatric research for the ongoing year. 🚀    Happy to announce our next Team Building that will take place in Tirana (September 2025), where we'll celebrate 25 years of CVBF's growth and 10 years of CVBF Albania! 🎉    Together, we continue building on our tradition of excellence in clinical research. 📈    #CVBF #ClinicalResearch #TeamBuilding #Healthcare #Research #Growth #Anniversary https://lnkd.in/dvBWtwjk

🎉 Celebrating 25 Years of Excellence at CVBF! We just concluded an inspiring two-day team building and anniversary celebration, bringing together our team from Pavia, Tirana, and Bari to our headquarters. Beyond strengthening team bonds and planning for the future, our colleagues had the opportunity to explore the beautiful city of Bari together. A special thank you to all our collaborators, partners, and stakeholders who have been part of our 25-year journey. Your trust and support have been instrumental in our success story.  Here's to many more years of collaboration and innovation! 🚀  #CVBF25 #TeamBuilding #OrganizationAnniversary #Milestone #TeamCVBF

🎉 CVBF obtains the Family Audit Executive Certification! We are proud to announce that CVBF has achieved the Family Audit Executive Certification, recognizing our commitment to promoting work-life balance policies and fostering organizational well-being.  In recent years, we have introduced tangible initiatives to enhance the quality of life for our employees, including:   ✅ Flexible working hours for entry and exit   ✅ Baby bonuses for new births   ✅ Performance-based reward systems   ✅ Financial reimbursements for unexpected family care needs  These measures have not only improved the well-being of our team but have also strengthened employee loyalty, fostering longer tenure and sustainable growth across our workforce.  The certification does not represent a final destination but rather serves as motivation to continue our commitment to creating a workplace that is increasingly inclusive and responsive to everyone's needs. #Inclusion #WorkLifeBalance #FamilyAudit #GenderEquality #OrganizationalWellBeing #Teamwork

Merry Christmas and a Happy and Successful New Year! 🎄

🔬 An Analysis on Paediatric Post-Authorization Studies🧬    Our team has just published an analysis of paediatric Post-Authorization Studies, revealing critical insights into drug research for children.    Key Highlights from the 165 analysed paediatric studies (2010-2023):  86% observational studies  62% funded by pharmaceutical companies  Anti-infectives, nervous system, and antineoplastic drugs    The research underscores the urgent need for:  ✔️ Enhanced industry-academia collaboration  ✔️ Increased regulatory guidance  ✔️ Targeted research in areas with unmet therapeutic need  ✔️ Improved study transparency    Why this matters: Children are often excluded from pre-authorization trials, making post-authorization studies crucial for understanding drug safety and efficacy.    For more info and the full paper: https://lnkd.in/dUcWy8_x TEDDY Network | Fondazione per la Ricerca Farmacologica Gianni Benzi ONLUS #PaediatricResearch #ClinicalResearch #PAS #Registry 

🌟CVBF at the Global CardioVascular Clinical Trialists Forum 🩺🔬   Our CEO, Donato Bonifazi and Member of the Board of Directors at TEDDY Network, presented at the CVCT Forum in Washington DC, sharing insights on paediatric clinical trials and regulatory approaches.   Presentations focused on drug candidate selection and real-world data in clinical research.   Want to know more? 👉 Full details available on our website: https://lnkd.in/d_ecRSTA   #MedicalResearch #ClinicalTrials #Healthcare #CVCT

2025 Joint Transnational Call for Proposals focused on pre-clinical therapy studies for rare diseases using small molecules and biologicals. 🧬🌍 This call offers a unique opportunity for researchers worldwide to collaborate on groundbreaking research that can potentially improve the lives of millions affected by rare diseases. 📅 Important Dates: - Call Opens: December 10, 2024 - Pre-Proposal Deadline: February 13, 2025

Since its inception, CVBF has been more than just a research organization - it's a mission-driven community dedicated to transforming the landscape of paediatric and rare disease research. We dedicate a special focus on paediatric populations, where each breakthrough can mean a world of difference for children and families facing extraordinary challenges. This newsletter showcases our unwavering commitment and our journey from international conferences to groundbreaking educational initiatives.

Excited to share that Dr. Annagrazia Altavilla, PhD, HDR, responsible of International Relations of Espace Éthique Méditerranéen/PACA Corse (AP-HM/AixMarseille University – France) and past Chair of the TEDDY Network of Excellence, has made a significant contribution to the EJP RD "Innovative Therapies and Personalized Medicine for Rare Disease" MOOC, led by CVBF. 🧠 Dr. Altavilla sheds light on the evolving ethical and legal landscape surrounding the sharing and reuse of personal data for rare disease research, drawing on her deep expertise in medical ethics and the GDPR. 🔍 Check out the MOOC: https://lnkd.in/dgAwnQzx and read the full article to learn more: https://lnkd.in/dX3ib-Dp   #RareDiseases #GDPR #Healthcare #Research #EJPRD #MOOC